ISSN 2394-5125
 

Research Article 


BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari.

Abstract
Coronavirus disease (COVID-19) is a pandemic disease appeared in China in December 2019 and has since spread throughout the world. The recent outbreak of acute respiratory infection is caused by a new type of coronavirus, named as (SARS-CoV-2). At the moment, there are no specific medications or vaccines to treat COVID-19. Recently, a combination of the antimalarial hydroxychloroquine (HCQ) and azithromycin (AZM) antibiotic is used effectively in treatment of COVID-19. The present article discusses the possibility of the development of a new cost-effective pharmaceutical product combing HCQ and AZM in management of coronavirus infections. Such an approach would involve waiving of the in-vivo bioavailability and bioequivalence studies of the conventional oral dosage forms for emergency approval from regulatory affair authorities.

Key words: Hydroxychloroquine, Azithromycin, COVID-19, Coronavirus, SARS-CoV-2, Antimalarial, Biowaiver, BCS, Cost effective


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bhupendra Kumar
Articles by Nisha Agari
Articles by Yogesh Tiwari
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. JCR. 2020; 7(19): 1943-1951. doi:10.31838/jcr.07.19.236


Web Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. http://www.jcreview.com/?mno=108233 [Access: September 14, 2020]. doi:10.31838/jcr.07.19.236


AMA (American Medical Association) Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. JCR. 2020; 7(19): 1943-1951. doi:10.31838/jcr.07.19.236



Vancouver/ICMJE Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. JCR. (2020), [cited September 14, 2020]; 7(19): 1943-1951. doi:10.31838/jcr.07.19.236



Harvard Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari (2020) BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. JCR, 7 (19), 1943-1951. doi:10.31838/jcr.07.19.236



Turabian Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. 2020. BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. Journal of Critical Reviews, 7 (19), 1943-1951. doi:10.31838/jcr.07.19.236



Chicago Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. "BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK." Journal of Critical Reviews 7 (2020), 1943-1951. doi:10.31838/jcr.07.19.236



MLA (The Modern Language Association) Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari. "BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK." Journal of Critical Reviews 7.19 (2020), 1943-1951. Print. doi:10.31838/jcr.07.19.236



APA (American Psychological Association) Style

Bhupendra Kumar, Nisha Agari, Yogesh Tiwari (2020) BCS BASED BIOWAIVER AS A RAPID TOOL FOR THE PROPOSED PHARMACEUTICAL PRODUCTS SUPPORT FOR COVID-19 OUTBREAK. Journal of Critical Reviews, 7 (19), 1943-1951. doi:10.31838/jcr.07.19.236